Whole-Genome Landscape of Retinal Hemangioblastomas
Translational Vision Science & Technology · 2026
DOI: 10.1167/tvst.15.1.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2026. Verfasst von Kiki Bals und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Erasmus MC, CA Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Hemangioblastoma, Retinal Neoplasms. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Retinal hemangioblastomas (RHs) are rare benign vascular tumors that present mostly as manifestations of Von Hippel-Lindau (VHL) syndrome. In contrast to other VHL syndrome-associated tumors, only a handful of molecular studies have been published on RHs. It remains unclear whether VHL alterations alone drive RH tumorigenesis.
Methods
Whole-genome sequencing (WGS) was performed on germline- and RHs-derived DNA of five patients. Additionally, transcriptomes of four unaffected retinas and five choroid controls were compared with those of RH biopsies.
Results
Heterozygous germline missense variants and copy number losses impacting VHL were identified. In all RH biopsies, mosaic loss of chromosome 3 was present, indicating the "second hit" in RHs is likely loss of the complete wild-type chromosome 3. Few additional somatic short nucleotide variants (SNVs) indels, or structural variants with deleterious potential were detected, suggesting that somatic changes are rare but not limited to the VHL gene region. RNA sequencing revealed reduced VHL expression in tumor tissue and downstream gene expression changes consistent with loss of VHL expression.
Conclusions
RHs have few somatic changes. Loss of chromosome 3 is likely the second hit in RHs with germline VHL alterations. Translational Relevance: RHs are benign neoplasms with little somatic changes compared with other VHL-syndrome associated tumors. Variants affecting VHL impact downstream gene expression, variants impacting different VHL domains result in differential gene expression of these downstream targets. RNA sequencing may aid in the evaluation of variants of unknown significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Erasmus MC, CA Rotterdam, The Netherlands.
- Department of Clinical Genetics, Erasmus MC, CA Rotterdam, The Netherlands.
- Erasmus MC Cancer Institute, CA Rotterdam, The Netherlands.
- Department of Vitreoretinal Surgery, Rotterdam Eye Hospital, LM Rotterdam, The Netherlands.
- Department of Ophthalmology, ZAS Cadix, Antwerpen, Belgium.
- Department of Pediatric Surgery, Sophia Children's Hospital, Erasmus MC, CA Rotterdam, The Netherlands.
Zitieren
APA
Bals, K., Hajjaj, A., van Overdam, K. A., Veckeneer, M., de Graaf, B. M., Eussen, B., Brands, T., Oldenburg, R. A., Alves, M. M., Verdijk, R. M., de Klein, A., Kiliç, E., Brosens, E., & Rotterdam Ocular Melanoma Study Group (2026). Whole-Genome Landscape of Retinal Hemangioblastomas. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.15.1.5
Vancouver
Bals K, Hajjaj A, van Overdam KA, Veckeneer M, de Graaf BM, Eussen B, et al. Whole-Genome Landscape of Retinal Hemangioblastomas. Translational Vision Science & Technology. 2026. doi:10.1167/tvst.15.1.5
BibTeX
@article{Bals2026,
author = {Bals, Kiki and Hajjaj, Anass and van Overdam, Koen A and Veckeneer, Marc and de Graaf, Bianca M and Eussen, Bert and Brands, Tom and Oldenburg, Rogier A and Alves, Maria M and Verdijk, Robert M and de Klein, Annelies and Kiliç, Emine and Brosens, Erwin and Rotterdam Ocular Melanoma Study Group, Rotterdam Ocular Melanoma Study Group},
title = {Whole-Genome Landscape of Retinal Hemangioblastomas},
journal = {Translational Vision Science & Technology},
year = {2026},
doi = {10.1167/tvst.15.1.5}
}
EUVIMED